This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Robert-Gero, M. Articles by Vigier, P. Search for Related Content PubMed PubMed Citation Articles by Robert-Gero, M. Articles by Vigier, P.

Inhibition by Methioninyl Adenylate of Focus Formation by Rous Sarcoma Virus¹

Institut de Chimie des Substances Naturelles, Centre National de Recherche Scientifique, 91-Gif/Yvette [M. R-G., F. L.], and Institut du Radium (Biologie), Faculté des Sciences, 91-Orsay, France [P. V.]

Methioninyl adenylate is a specific and potent inhibitor of the enzyme methionyl-tRNA synthetase and, consequently, of protein biosynthesis. In cultures of chick embryo fibroblasts infected with Rous sarcoma virus, incubation for a 2-day period with 1 to 3 mM concentrations of this inhibitor, as late as 4 days after infection, irreversibly prevented subsequent formation of foci of transformed cells. Later addition could also elicit the irreversible disappearance of already existing foci, by phenotypic reversion and/or cell killing. Virus production in transformed cells and replication in newly infected cells were also inhibited but to a lesser degree. Under the same conditions, the same concentrations of methioninyl adenylate caused only a reversible growth arrest of normal cells. The selective toxicity of the inhibitor for transformed cells is not due to a greater affinity for the target enzyme, but it may be due to the fact that inhibition of protein biosynthesis is only partially reversible in these cells, whereas it is fully reversible in normal cells.

¹ Supported by Special Cancer Virus Contract NO1 CP 43219 of the National Cancer Institute, Bethesda, Md.

Received 3/ 4/75. Accepted 8/ 6/75.